Initial Experience With Lung Donation After Cardiocirculatory Death in Canada

Journal of Heart and Lung Transplantation

Volumn 28, Issue 8, 2009, Pages 753-758

  Cypel, Marcelo ^a   Sato, Masaaki ^a   Yildirim, Erkan ^a   Karolak, Wojtek ^a   Chen, Fengshi ^a   Yeung, Jonathan ^a   Boasquevisque, Carlos ^a   Leist, Victoria ^b   Singer, Lianne G ^a   Yasufuku, Kazuhiro ^a   DePerrot, Marc ^a   Waddell, Thomas K ^a   Keshavjee, Shaf ^a   Pierre, Andrew ^a  

^a UNIVERSITY OF TORONTO   (Canada)

^b Trillium Gift of Life Network   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOSUPPRESSIVE AGENT;

ADULT; AGED; ARTICLE; BRONCHIOLITIS OBLITERANS; BRONCHOSCOPY; CANADA; CLINICAL ARTICLE; CONTROLLED STUDY; EXTRACORPOREAL OXYGENATION; FEMALE; FIBROSING ALVEOLITIS; GRAFT SURVIVAL; HEART DEATH; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INTENSIVE CARE UNIT; LUNG EMPHYSEMA; LUNG FIBROSIS; LUNG FUNCTION; LUNG GRAFT REJECTION; LUNG TRANSPLANTATION; MALE; MORTALITY; ORGAN DONOR; PRIORITY JOURNAL; SCORING SYSTEM;

ADOLESCENT; ADULT; CANADA; DEATH; FEMALE; HEART ARREST; HUMANS; LUNG TRANSPLANTATION; MALE; MIDDLE AGED; PATIENT SELECTION; TISSUE AND ORGAN HARVESTING; TISSUE AND ORGAN PROCUREMENT; TISSUE DONORS; TREATMENT OUTCOME;

EID: 67650998492     PISSN: 10532498     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.healun.2009.05.009     Document Type: Article

References (40)

1. De Meester J., Smits J., Persijn G., and Haverich A. Listing for lung transplantation: life expectancy and transplant effect, stratified by type of end-stage lung disease, the Eurotransplant experience. J Heart Lung Transplant 20 (2001) 518-524
2. de Perrot M., Liu M., Waddell T., and Keshavjee S. Ischemia-reperfusion-induced lung injury. Am J Respir Cell Mol Biol 28 (2003) 616-625
3. Punch J.D., Hayes D.H., LaPorte F.B., McBride V., and Seely M.S. Organ donation and utilization in the United States, 1996-2005. Am J Transplant 7 (2007) 1327-1338
4. Daemen J.W., Kootstra G., Wijnen R.M., Yin M., and Heineman E. Nonheart-beating donors: the Maastricht experience. Clin Transpl (1994) 303-316
5. Snell G.I., Oto T., Levvey B., McEgan R., Mennan M., and T H. Evaluation of techniques for lung transplantation following donation after cardiac death. Ann Thorac Surg 81 (2006) 2014-2019
6. Steen S., Sjoberg T., Pierre L., Liao Q., Eriksson L., and Algotsson L. Transplantation of lungs from a non-heart-beating donor. Lancet 357 (2001) 825-829
7. Snell G.I., Levvey B.J., Oto T., et al. Early lung transplantation success utilizing controlled donation after cardiac death donors. Am J Transplant 8 (2008) 1282-1289
8. Mason D.P., Murthy S.C., Gonzalez-Stawinski G.V., et al. Early experience with lung transplantation using donors after cardiac death. J Heart Lung Transplant 27 (2008) 561-563
9. Mason D.P., Thuita L., Alster J.M., et al. Should lung transplantation be performed using donation after cardiac death?. The United States experience. J Thorac Cardiovasc Surg 136 (2008) 1061-1066
10. Barnieh L., Baxter D., Boiteau P., Manns B., and Doig C. Benchmarking performance in organ donation programs: dependence on demographics and mortality rates. Can J Anaesth 53 (2006) 727-731
11. Trilliam Gift of Life Network. New era for organ donation in Canada: donation after cardiac death performed successfully in Ottawa [press release]. www.giftoflife.on.ca/assets/pdfs/NeweraJune06.pdf Last accessed: May 12, 2009
12. Orens J.B., Boehler A., de Perrot M., et al. A review of lung transplant donor acceptability criteria. J Heart Lung Transplant 22 (2003) 1183-1200
13. Botha P., Trivedi D., Weir C.J., et al. Extended donor criteria in lung transplantation: impact on organ allocation. J Thorac Cardiovasc Surg 131 (2006) 1154-1160
14. Pierre A., Sekine Y., Hutcheon M.A., Waddell T.K., and Keshavjee S. Marginal donor lungs: a reassessment. J Thorac Cardiovasc Surg 123 (2002) 421-427
15. Cypel M., Yeung J.C., Hirayama S., et al. Technique for prolonged normothermic ex vivo lung perfusion. J Heart Lung Transplant 27 (2008) 1319-1325
16. Fischer S., Matte-Martyn A., De Perrot M., et al. Low-potassium dextran preservation solution improves lung function after human lung transplantation. J Thorac Cardiovasc Surg 121 (2001) 594-596
17. de Perrot M., Chaparro C., McRae K., et al. Twenty-year experience of lung transplantation at a single center: influence of recipient diagnosis on long-term survival. J Thorac Cardiovasc Surg 127 (2004) 1493-1501
18. Lewis J., Peltier J., Nelson H., et al. Development of the University of Wisconsin donation After Cardiac Death Evaluation Tool. Prog Transplant 13 (2003) 265-273
19. Christie J.D., Carby M., Bag R., Corris P., Hertz M., and Weill D. Report of the ISHLT Working Group on Primary Lung Graft Dysfunction part II: definition. A consensus statement of the International Society for Heart and Lung Transplantation. J Heart Lung Transplant 24 (2005) 1454-1459
20. Edwards J., Mulvania P., Robertson V., et al. Maximizing organ donation opportunities through donation after cardiac death. Crit Care Nurse 26 (2006) 101-115
21. Stewart S., Fishbein M.C., Snell G.I., et al. Revision of the 1996 working formulation for the standardization of nomenclature in the diagnosis of lung rejection. J Heart Lung Transplant 26 (2007) 1229-1242
22. de Perrot M., Bonser R.S., Dark J., et al. Report of the ISHLT Working Group on Primary Lung Graft Dysfunction part III: donor-related risk factors and markers. J Heart Lung Transplant 24 (2005) 1460-1467
23. Sekine Y., Waddell T.K., Matte-Martyn A., et al. Risk quantification of early outcome after lung transplantation: donor, recipient, operative, and post-transplant parameters. J Heart Lung Transplant 23 (2004) 96-104
24. Barr M.L., Kawut S.M., Whelan T.P., et al. Report of the ISHLT Working Group on Primary Lung Graft Dysfunction part IV: recipient-related risk factors and markers. J Heart Lung Transplant 24 (2005) 1468-1482
25. Hartwig M.G., and Davis R.D. Surgical considerations in lung transplantation: transplant operation and early postoperative management. Respir Care Clin N Am 10 (2004) 473-504
26. de Antonio D.G., Marcos R., Laporta R., et al. Results of clinical lung transplant from uncontrolled non-heart-beating donors. J Heart Lung Transplant 26 (2007) 529-534
27. Rega F.R., Jannis N.C., Verleden G.M., Lerut T.E., and Van Raemdonck D.E. Long-term preservation with interim evaluation of lungs from a non-heart-beating donor after a warm ischemic interval of 90 minutes. Ann Surg 238 (2003) 782-792
28. Neyrinck A.P., Van De Wauewer C., Geudens N., Rega F.R., and Verleden G.M. Wouters Comparative study of donor lung injury in heart-beating versus non-heart-beating donors. Eur J Cardiothorac Surg 30 (2006) 628-636
29. Geudens N., Vanaudenaerde B.M., Neyrinck A.P., et al. Impact of warm ischemia on different leukocytes in bronchoalveolar lavage from mouse lung: possible new targets to condition the pulmonary graft from the non-heart-beating donor. J Heart Lung Transplant 25 (2006) 839-846
30. Rega F.R., Vanaudenaerde B.M., Wuyts W.A., Jannis N.C., Verleden G.M., and TE L. IL-1beta in bronchial lavage fluid is a non-invasive marker that predicts the viability of the pulmonary graft from the non-heart-beating donor. J Heart Lung Transplant 24 (2003) 20-28
31. Bharat A., Narayanan K., Street T., et al. Early posttransplant inflammation promotes the development of alloimmunity and chronic human lung allograft rejection. Transplantation 83 (2007) 150-158
32. Nijkamp D.M., van der Bij W., Verschuuren E.A., Heemskerk M.B., de Buijzer E., and Erasmus M.E. Non-heart-beating lung donation: how big is the pool?. J Heart Lung Transplant 27 (2008) 1040-1042
33. Steen S., Liao Q., Wierup P.N., Bolys R., Pierre L., and Sjöberg T. Transplantation of lungs from non-heart-beating donors after functional assessment ex vivo. Ann Thorac Surg 76 (2003) 244-252
34. Egan T.M., Haitchcock J.A., Nicotra W.A., Koukoulis G., Inokawa H., and Sevala M. Ex vivo evaluation of human lungs for transplant suitability. Ann Thorac Surg 81 (2006) 1205-1213
35. Wierup P., Haraldsson A., Nilsson F., et al. Ex vivo evaluation of nonacceptable donor lungs. Ann Thorac Surg 81 (2006) 460-466
36. Erasmus M.E., Fernhout M.H., Elstrodt J.M., and Rakhorst G. Normothermic ex vivo lung perfusion of non-heart-beating donor lungs in pigs: from pretransplant function analysis towards a 6-h machine preservation. Transplant Int 19 (2006) 589-593
37. Kaneda H., Waddell T.K., de Perrot M., et al. Pre-implantation multiple cytokine mRNA expression analysis of donor lung grafts predicts survival after lung transplantation in humans. Am J Transplant 6 (2006) 544-551
38. De Perrot M., Sekine Y., Fischer S., et al. Interleukin-8 release during early reperfusion predicts graft function in human lung transplantation. Am J Respir Crit Care Med 165 (2002) 211-215
39. Fisher A.J., Donnelly S.C., Hirani N., et al. Elevated levels of interleukin-8 in donor lungs is associated with early graft failure after lung transplantation. Am J Respir Crit Care Med 163 (2001) 259-265
40. Kang C., Cypel M., Sato M., et al. Donor lungs from donation after cardiac death have a decreased inflammatory cytokine profile compared to lungs from brain dead donors. J Heart Lung Transplant 28 (2009) S149